In vitro and in vivo evaluation of bone formation using solid freeform fabrication-based bone morphogenic protein-2 releasing PCL/PLGA scaffolds

Biomedical Materials (Bristol)

Volumn 9, Issue 2, 2014, Pages

  Kim, Tae Hoon ^a   Yun, Young Pil ^b   Park, Young Eun ^b   Lee, Suk Ha ^a   Yong, Woonjae ^c   Kundu, Joydip ^c   Jung, Jin Woo ^c   Shim, Jin Hyung ^c   Cho, Dong Woo ^c   Kim, Sung Eun ^b   Song, Hae Ryong ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

bone formation; bone morphogenic protein 2 (BMP 2); freeform fabrication (SFF); osteoblast activity; poly(lactic co glycolic acid) (PLGA); polycaprolactone (PCL); solid

Indexed keywords

BONE; CALCIUM; CELL PROLIFERATION; COMPUTERIZED TOMOGRAPHY; COPOLYMERS; DEPOSITION; PHOSPHATASES; PHOTOELECTRONS; POLYCAPROLACTONE; RADIOGRAPHY; RATS; SCANNING ELECTRON MICROSCOPY; SOLIDS; X RAY PHOTOELECTRON SPECTROSCOPY;

ALKALINE PHOSPHATASE ACTIVITY; BONE FORMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEFORM FABRICATION; GLYCOLIC ACIDS; MICRO COMPUTED TOMOGRAPHY (MICRO-CT); MORPHOGENIC; SURFACE ELEMENTAL COMPOSITIONS;

SCAFFOLDS (BIOLOGY);

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; DOPAMINE; HEPARIN; POLYCAPROLACTONE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTECHNOLOGY; BONE MINERALIZATION; BONE RADIOGRAPHY; CALLUS; CELL PROLIFERATION; CELL VIABILITY; CONJUGATE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; OSTEOBLAST; RAT; SCANNING ELECTRON MICROSCOPE; SCANNING ELECTRON MICROSCOPY; SOLID FREEFORM FABRICATION; SURFACE PROPERTY; X RAY PHOTOELECTRON SPECTROSCOPY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CELL LINE, TUMOR; CELL PROLIFERATION; DIHYDROXYPHENYLALANINE; DOPAMINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMUR; HEPARIN; HUMANS; LACTIC ACID; OSTEOBLASTS; OSTEOGENESIS; PHOTOELECTRON SPECTROSCOPY; POLYGLYCOLIC ACID; RATS; SURFACE PROPERTIES; X-RAY MICROTOMOGRAPHY;

EID: 84896846150     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/9/2/025008     Document Type: Article

References (47)

1. Bohner M 2001 Physical and chemical aspects of calcium phosphates used in spinal surgery Eur. Spine J. 10 S114-21
2. Tadic D and Epple M 2004 A thorough physicochemical characterisation of 14 calcium phosphate-based bone substitution materials in comparison to natural bone Biomaterials 25 987-94
3. Dorozhkin S V and Epple M 2002 Biological and medical significance of calcium phosphates Angew. Chem. Int. Edn Engl. 41 3130-46
4. King W J and Krebsbach P H 2012 Growth factor delivery: how surface interactions modulate release in vitro and in vivo Adv. Drug Deliv. Rev. 64 1239-56
5. Cook S D, Wolfe M W, Salkeld S L and Rueger D C 1995 Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates J. Bone Joint Surg. Am. 77 734-50
6. Kim S E et al 2008 Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells J. Biomed. Sci. 15 771-7
7. Wang E A et al 1990 Recombinant human bone morphogenetic protein induces bone formation Proc. Natl Acad. Sci. USA 87 2220-4
8. Lecanda F, Avioli L V and Cheng S L 1997 Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2 J. Cell. Biochem. 67 386-96
9. Diefenderfer D L, Osyczka A M, Garino J P and Leboy P S 2003 Regulation of BMP-induced transcription in cultured human bone marrow stromal cells J. Bone Joint. Surg. Am. 85-A 19-28
10. Seeherman H and Wozney J M 2005 Delivery of bone morphogenetic proteins for orthopedic tissue regeneration Cytokine Growth Factor Rev. 16 329-45
11. Shields L B et al 2006 Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion Spine 31 542-7
12. Cho T J, Gerstenfeld L C and Einhorn T A 2002 Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing J. Bone Miner. Res. 17 513-20
13. Tagil M, Jeppsson C, Wang J S and Aspenberg P 2003 No augmentation of morselized and impacted bone graft by OP-1 in a weight-bearing model Acta Orthop. Scand. 74 742-8
14. Kim S E et al 2011 The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function Biomaterials 32 366-73
15. Sasisekharan R, Ernst S and Venkataraman G 1997 On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans Angiogenesis 1 45-54
16. Jeon O, Ryu S H, Chung J H and Kim B S 2005 Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin J. Control. Release 105 249-59
17. Briganti E et al 2010 A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors J. Control. Release 142 14-21
18. Lee H, Scherer N F and Messersmith P B 2006 Single-molecule mechanics of mussel adhesion Proc. Natl Acad. Sci. USA 103 12999-3003
19. Fan X, Lin L, Dalsin J L and Messersmith P B 2005 Biomimetic anchor for surface-initiated polymerization from metal substrates J. Am. Chem. Soc. 127 15843-7
20. Lee H, Dellatore S M, Miller W M and Messersmith P B 2007 Mussel-inspired surface chemistry for multifunctional coatings Science 318 426-30
21. Lee D W, Yun Y P, Park K and Kim S E 2012 Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinized-titanium implant with enhanced antibacterial activity and osteointegration Bone 50 974-82
22. Mehrabanian M and Nasr-Esfahani M 2011 HA/nylon 6,6 porous scaffolds fabricated by salt-leaching/solvent casting technique: effect of nano-sized filler content on scaffold properties Int. J. Nanomed. 6 1651-9
23. Petrie Aronin C E, Cooper J A Jr, Sefcik L S, Tholpady S S, Ogle R C and Botchwey E A 2008 Osteogenic differentiation of dura mater stem cells cultured in vitro on three-dimensional porous scaffolds of poly(epsilon-caprolactone) fabricated via co-extrusion and gas foaming Acta Biomater. 4 1187-97
24. Ko J, Kolehmainen K, Ahmed F, Jun M B and Willerth S M 2012 Towards high throughput tissue engineering: development of chitosan-calcium phosphate scaffolds for engineering bone tissue from embryonic stem cells Am. J. Stem Cells 1 81-89
25. Lee H Y, Jin G Z, Shin U S, Kim J H and Kim H W 2012 Novel porous scaffolds of poly(lactic acid) produced by phase-separation using room temperature ionic liquid and the assessments of biocompatibility J. Mater. Sci., Mater. Med. 23 1271-9
26. Kim J Y, Lee T J, Cho D W and Kim B S 2010 Solid free-form fabrication-based PCL/HA scaffolds fabricated with a multi-head deposition system for bone tissue engineering J. Biomater. Sci. Polym. Edn 21 951-62
27. Kim J Y et al 2010 Evaluation of solid free-form fabrication-based scaffolds seeded with osteoblasts and human umbilical vein endothelial cells for use in vivo osteogenesis Tissue Eng. 16 2229-36
28. Lee J W, Kang K S, Lee S H, Kim J Y, Lee B K and Cho D W 2011 Bone regeneration using a microstereolithography-produced customized poly(propylene fumarate)/diethyl fumarate photopolymer 3D scaffold incorporating BMP-2 loaded PLGA microspheres Biomaterials 32 744-52
29. Slosar P J, Josey R and Reynolds J 2007 Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes Spine J. 7 301-7
30. Villavicencio A T, Burneikiene S, Nelson E L, Bulsara K R, Favors M and Thramann J 2005 Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2 J. Neurosurg. Spine 3 436-43
31. McClellan J W, Mulconrey D S, Forbes R J and Fullmer N 2006 Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2) J. Spinal Disord. Tech. 19 483-6
32. Singh K, Smucker J D, Gill S and Boden S D 2006 Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years J. Spinal Disord. Tech. 19 416-23
33. Boden S D, Kang J, Sandhu H and Heller J G 2002 Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo award in clinical studies Spine 27 2662-73
34. Lewandrowski K U, Nanson C and Calderon R 2007 Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases Spine J 7 609-14
35. King G N, King N, Cruchley A T, Wozney J M and Hughes F J 1997 Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects J. Dent. Res. 76 1460-70
36. Zellin G and Linde A 1997 Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects J. Biomed. Mater. Res. 35 181-90
37. Kim J et al 2007 Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells Biomaterials 28 1830-7
38. Shi Z, Neoh K G, Kang E T, Poh C and Wang W 2009 Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions Tissue Eng. 15 417-26
39. Chua P H, Neoh K G, Kang E T and Wang W 2008 Surface functionalization of titanium with hyaluronic acid/chitosan polyelectrolyte multilayers and RGD for promoting osteoblast functions and inhibiting bacterial adhesion Biomaterials 29 1412-21
40. Lee T C, Ho J T, Hung K S, Chen W F, Chung Y H and Yang Y L 2006 Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment Neurosurgery 58 373-80
41. Huh J B et al 2011 The effect of immobilization of heparin and bone morphogenic protein-2 to bovine bone substitute on osteoblast-like cell's function J. Adv. Prosthodont. 3 145-51
42. Chung H J, Kim H K, Yoon J J and Park T G 2006 Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery Pharm. Res. 23 1835-41
43. Yoon J J, Chung H J, Lee H J and Park T G 2006 Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor J. Biomed. Mater. Res. 79 934-42
44. Cope J B and Samchukov M L 2001 Mineralization dynamics of regenerate bone during mandibular osteodistraction Int. J. Oral Maxillofac. Surg. 30 234-42
45. Chu T M, Warden S J, Turner C H and Stewart R L 2007 Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2 Biomaterials 28 459-67
46. Oest M E, Dupont K M, Kong H J, Mooney D J and Guldberg R E 2007 Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects J. Orthop. Res. 25 941-50
47. Henslee A M et al 2011 Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects Acta Biomater. 7 3627-37